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Abscess
lung, ampicillin + sulbactam vs clindamycin ±
cephalosporin 163
soft-tissue, caused by Salmonella enterica serovar
Enteritidis at site of melanoma metastasis
(correspondence) 86
Acinetobacter spp., antimicrobial resistance in
Europe 684 (review), 1106
(correspondence)
Acinetobacter baumannii
endocarditis, colistin efficacy in experimental
model (research note) 581
morphological changes induced by imipenem
and meropenem at sub-inhibitory
concentrations (research note) 931
synergistic activity of imipenem and sulbactam
(research note) 1098
use of inhaled ampicillin—sulbactam against
multiresistant strains in ICU patients
(correspondence) 85
Actinobacillus actinomycetemcomitans endocarditis
(review) 98
Aerobactin, production by Escherichia coli
and pathogenic role (research note)
1011
Agar dilution, oxacillin susceptibility testing in
coagulase-negative staphylococci (research
note) 462
AIDS
novel sequevar of Mycobacterium flavescens
(research note) 1017
oropharyngeal candidiasis, caspofungin
therapy (editorial) 187
see also HIV
Albendazole, childhood giardiasis 527
Amikacin resistance in Pseudomonas aeruginosa,
MexXY efflux pump and 877
Amoxycillin—clavulanic acid resistance
mechanisms, Escherichia coli 234
Amoxycillin-resistant Enterococcus faecium,
microbiological and epidemiological
studies 441
Amphotericin B
with caspofungin, fungal pneumonia in
leukaemia and bone marrow transplant
patients (research note) 255
nephrotoxicity: pharmacosurveillance study
785
with voriconazole, invasive pulmonary
aspergillosis (research note) 925
Ampicillin—sulbactam, inhaled, use against
multiresistant Acinetobacter baumannii in
ITU patients (correspondence) 85
Anaerobic bacteria, aspiration pneumonia,
ampicillin + sulbactam vs clindamycin ±
cephalosporin 163
Anthrax, immunity testing using Bacillus anthracis
extractable antigens 421
Antibiotics
b-lactam
combined with vancomycin, false synergy in
treatment for glycopeptide-resistant
Staphylococcus aureus (research note) 342
relationship between pharmacokinetics and
pharmacodynamics 990
use, impact of infectious disease specialists 911
see also names of specific drugs
Antifungal drugs
combined use in aspergillosis 961
see also names of specific drugs
Antimicrobial resistance
Acinetobacter spp. in Europe 684 (review), 1106
(correspondence)
amoxycillin—clavulanic acid resistance in
Escherichia coli 234
amoxycillin-resistant Enterococcus faecium 441
antibiotic resistance surveillance systems
(review) 502
bloodstream infections in cancer patients
542
carriage of resistant organisms in repatriates
from foreign hospitals 972
E.coli and Shigella spp., Egyptian paediatric
populations 804
efflux-mediated multiresistance in
Gram-negative bacteria (review) 12
evolution of acquired resistance in
Enterobacteriaceae to third-generation
cephalosporins (research note) 665
fluoroquinolone resistance in Streptococcus
pyogenes isolate (research note) 657
glycopeptide-resistant enterococci
absence of carriage in hospitalised patients
in Malta (correspondence) 861
inter-hospital dissemination (research note)
260
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HIV resistance mutations in patients naı¨ve for
antiretrovirals 826
integrons (review) 272
intestinal Gram-negative flora and enterococci,
influence of rifaximin (research note) 1009
intestinal Staphylococcus aureus in infants 890
invasive pneumococcal isolates
in children up to 5 years (research note) 177
Ireland (research note) 657
metronidazole resistance determination in
Helicobacter pylori 315, 1105
(correspondence)
multi-drug resistant Salmonella Typhimurium
904
quinolone resistance in Escherichia coli from
community-acquired urinary tract
infections (research note) 75
relationship between ciprofloxacin resistance
and extended-spectrum b-lactamase
production in Escherichia coli and Klebsiella
pneumoniae (research note) 72
respiratory pathogens, Brazil 521
rifampicin resistance in Mycobacterium
tuberculosis, rpoB mutations and 289
role of research in combating (Report of
European Conference, 2003) 473
Streptococcus pneumoniae resistance to
macrolides (research note) 851
surveillance, European recommendations
(ESCMID Study Group report) 349
third-generation cephalosporin-resistant
Enterobacteriaceae in ICUs 436
tuberculosis in immigrants (research note) 335
Turicella otitidis (research note) 854
see also Glycopeptide-intermediate
Staphylococcus aureus; Methicillin-resistant
Staphylococcus aureus
Antimicrobial susceptibility
Leclercia adecarboxylata 724
Streptococcus agalactiae (correspondence) 267
Streptococcus pneumoniae in Latin America:
results from SENTRY program 645
Antimicrobial susceptibility testing
agar disk diffusion technique, OSIRIS video
reader as automated measurement system
416
broth microdilution panels, NCP PDF-713
(LBM 415) (peptide deformylase inhibitor)
(research note) 857
false synergy between vancomycin and b-
lactams against GISA caused by
inappropriate testing methods (research
note) 342
oxacillin, comparison of screening methods
(research note) 462
preparation of stock solutions of macrolide and
ketolide compounds (research note) 78
Antiretroviral drugs
effect on tuberculosis manifestations 388
HIV-1 resistance
pol gene insertions and 127
prevalence of resistance substitutions in
HIV-1 genes 826
Appendicitis, schistosomal (editorial) 89
Arthritis, septic, Streptococcus pneumoniae
(editorial) 1037
Aspergillosis
brain, voriconazole treatment (research note) 928
hospitalised veteran population
(correspondence) 679
invasive
challenges in diagnosis and therapy
(editorial) 2
voriconazole plus amphotericin B or
micafungin in guinea-pig model of
pulmonary disease (research note) 925
treatment with nikkomycin Z 961
Aspiration pneumonia, ampicillin + sulbactam vs
clindamycin ± cephalosporin 163
Asthma, investigation of possible association with
Chlamydia pneumoniae and Mycoplasma
pneumoniae antibodies (research note) 345
Astroviruses, gastroenteritis in Italian children/
typing (research note) 1025
Atherosclerosis development, effect of chronic
Pseudomonas aeruginosa infection 705
AZD2563, in-vitro properties 247
Bacillus anthracis extractable antigens for testing
anthrax immunity 421
Bactec blood culture system, preincubation
(research note) 1089
Bacteraemia
catheter-related 431
management of long-term Brevibacterium
infection (research note) 465
coagulase-negative Staphylococcus species,
quantitative antibiogram analysis of
clonality 148
detection by 16S rRNA gene PCR assay,
influence of DNA extraction method 452
diagnostic value of procalcitonin 628
Streptococcus pneumoniae, plasma levels of
soluble urokinase-type plasminogen
activator receptor 409
see also Bloodstream infections
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Bacteria
atypical, diagnosis of acute respiratory
infections using automated complement-
fixation test 220
see also names of specific bacteria
BCG immunisation, tuberculin reactivity and
booster effect 980
b-lactamases
b-lactamase-producing bacteria in mixed
infections (review) 777
extended-spectrum (ESBLs)
CTX-M-15-producing Escherichia coli and
Klebsiella pneumoniae (research note) 752
Escherichia coli and Klebsiella pneumoniae,
ciprofloxacin resistance and (research note)
72
evolution of acquired resistance to third-
generation cephalosporins in
Enterobacteriaceae (research note) 665
physician awareness and perception
(research note) 760
inhibitor-resistant, Escherichia coli 234
metallo-b-lactamase VIM-2 production by
Escherichia coli (research note) 757
b-lactams see Antibiotics, b-lactam
Bioassay, detection of disinfectant residues on clini-
cal materials by bacterial toxicity assay 984
Biochips (editorial) 865
Biofilm, Staphylococcus epidermidis, role of ica
operon 1081
Blood cultures
after-hours clinical liaison service 917
diagnosis of disseminated mycobacterial
infections 734
preincubation, Bactec system (research note)
1089
repeating 624
results in Greek tertiary care hospital (research
note) 667
significance of cultures positive for emerging
saprophytic moulds in cancer patients
(research note) 922
Blood donor screening, multiplex RT-PCR for
simultaneous detection of hepatitis C and
HIV 1075
Bloodstream infections
catheter-related 431
clinical-epidemiological characteristics and
outcome: European study (research note)
843
Staphylococcus aureus 309
surveillance in a cancer centre 542
see also Bacteraemia
Bone marrow, diagnosis of disseminated
mycobacterial infections 734
Bone marrow transplant patients, fungal
pneumonia, treatment with caspofungin
and amphotericin B or voriconazole
(research note) 255
Borreliosis, Lyme (review) 598
guidelines for diagnosis 1108
seroprevalence in forestry rangers 1056
Brevibacterium infection, catheter-related (research
note) 465
2-Bromo-2-nitro-1,3-propanediol, detection of
residue on clinical materials 984
Bronchiectasis, Helicobacter pylori in (research
note) 257
Brucellar spondylitis, diagnostic role of
sulesomab (research note) 1020
Burkholderia pseudomallei, cell-mediated immune
response to (research note) 585
Campylobacter spp. (review) 868
Cancer patients
bloodstream infection surveillance 542
significance of blood cultures positive for
saprophytic moulds (research note) 922
tuberculosis/corticosteroid therapy (research
note) 748
Candida spp.
risk factors for infection in critically ill patients
550
simplified sunflower seed agar for
differentiation of Candida dubliensis from
Candida albicans (research note) 590
Candidiasis, oropharyngeal, caspofungin therapy
(editorial) 187
Carbapenems, effect of sub-inhibitory
concentrations on Acinetobacter baumannii
(research note) 931
Caspofungin
with amphotericin B or voriconazole, fungal
pneumonia in leukaemia and bone
marrow transplant patients (research note)
255
oropharyngeal candidiasis (editorial) 187
Catheter-related infections
bloodstream, European study: clinical-
epidemiological characteristics and
outcome (ESGNI-006) (research note) 843
intravenous
bacteraemia and 431
European study: microbiology workload,
aetiology and antimicrobial susceptibility
(ESGNI-005 Study) 838
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long-term Brevibacterium infection management
(research note) 465
Staphylococcus epidermidis, ica operon expression
and role in biofilm production 1081
Cefepime, relationship between pharmacokinetics
and pharmacodynamics 990
Cefoxitin disk diffusion test, methicillin-resistant
Staphylococcus aureus (research note) 762
Ceftriaxone, relationship between
pharmacokinetics and pharmacodynamics
990
Cephalosporins, third-generation
acquired resistance in Enterobacteriaceae in
Tunisian hospital (research note) 665
resistant Enterobacteriaceae in ICU patients 436
use/avoidance against AmpC-inducible
Enterobacteriaceae (correspondence) 84
Cerebrospinal fluid, concentrations of fusidic acid
and rifampicin in Staphylococcus epidermidis
meningitis patients (research note) 765
Chickenpox see Varicella
Chlamydia pneumoniae
antibodies
possible association with asthma (research
note) 345
reproducibility of enzyme-linked
immunosorbent assay (research note) 171
HIV-infected patients 820
Ciprofloxacin resistance, relationship with
extended-spectrum b-lactamase production
in Escherichia coli and Klebsiella pneumoniae
strains (research note) 72
Clarithromycin, community-acquired pneumonia
403
Clavulanic acid see Amoxycillin—clavulanic acid
Coliforms, influence of rifaximin treatment on
susceptibility (research note) 1009
Colistin, efficacy in experimental Acinetobacter
baumannii endocarditis (research note)
581
ColorPAC assay, respiratory syncytial virus from
nasopharyngeal aspirates 967
Complement-fixation test, automated Seramat
system, diagnosis of acute respiratory
infections 220
Coronavirus, SARS-associated, chronological
evolution of antibodies 1062
Corticosteroid therapy and tuberculosis in cancer
patients (research note) 749
Crimean—Congo haemorrhagic fever 1047
Cryptococcus neoformans var. neoformans,
determination of mating type by multiplex
PCR (research note) 1092
Cytokine secretion, gemifloxacin inhibition by
lipopolysaccharide-stimulated monocytes
213
Cytomegalovirus (CMV)
ganciclovir prophylaxis of CMV disease in
kidney recipients undergoing anti-
lymphocyte globulin treatment (research
note) 337
mononucleosis in immunocompetent patients
(research note) 468
Dengue fever, serological investigation of
prevalence of anti-dengue IgM and IgG
antibodies (research note) 181
Dermacentor spp. as disease vector 327
Diagnostics, molecular
chip-mediated techniques (editorial) 865
real-time PCR (review) 190
Diarrhoea
antibiotic-resistant enteric bacteria, Egyptian
children 804
associated pathogens, rural Jordan 634
astrovirus infection, Italian children (research
note) 1025
Disinfectants, detection of residue on clinical
materials 984
Disk diffusion technique, OSIRIS video reader as
automated measurement system 416
DNA assays, quantitative (review) 5
DNA probe array, detection of rpoB gene
mutations 289
Drug users, hepatitis C infection (research note)
768
Dyspepsia, non-ulcer, distribution of vacA alleles
and cagA status of Helicobacter pylori
(research note) 1102
Ebola virus, matrix protein (research note) 945
Echinocandins
caspofungin as treatment for oropharyngeal
candidiasis (editorial) 187
combined with nikkomycin Z, activity against
Aspergillus fumigatus 961
Echovirus 13 outbreak in Lithuanian children
(research note) 1023
Efflux-mediated multiresistance in Gram-
negative bacteria (review) 12
Ehrlichiosis
guidelines for diagnosis 1108
seroprevalence in forestry rangers 1056
ELISA see Enzyme-linked immunosorbent assay
(ELISA)
Emboli, systemic, infective endocarditis 46
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Encephalitis
tick-borne (review) 1040
seroprevalence in forestry rangers 1056
West Nile, serum ferritin levels (research note)
184
Endocarditis, infective
Acinetobacter baumannii, colistin efficacy in
experimental model (research note) 581
Actinobacillus actinomycetemcomitans (review)
98
causative organisms according to host status
302
detection of bacterial DNA in cardiac
vegetations after completion of
antimicrobial therapy (research note) 579
enterococcal, virulence factors (research note)
1006
Greece: epidemiological, microbiological and
therapeutic data 556
risk factors for systemic emboli 46
Enterobacteriaceae
AmpC-inducible, use/avoidance of third-
generation cephalosporins
(correspondence) 84
third-generation cephalosporin resistance
acquired resistance in Tunisian hospital
(research note) 665
ICU patients 436
Enterobactin, production by Escherichia coli and
pathogenic role (research note) 1011
Enterococci
glycopeptide-resistant, absence of carriage in
hospitalised patients in Malta
(correspondence) 861
infective endocarditis in Greece 556
intestinal, influence on susceptibility of
rifaximin treatment (research note) 1009
vancomycin-resistant
carriage in repatriates from foreign hospitals
to The Netherlands 972
tertiary hospital in Crete 999
Enterococcus faecalis
endocarditis, virulence factors (research note)
999
glycopeptide-resistant, inter-hospital
dissemination (research note) 260
Enterococcus faecium, amoxycillin-resistant,
microbiological and epidemiological
studies 441
Enzyme immunoassays (EIAs)
dot-blot, respiratory syncytial virus in
nasopharyngeal aspirates 967
investigation of possible association between
Chlamydia pneumoniae and Mycoplasma
pneumoniae antibodies and asthma (research
note) 345
Mycoplasma pneumoniae detection in blood
donors and patients (research note) 1094
Enzyme-linked immunosorbent assay (ELISA)
detection of Chlamydia pneumoniae-specific
antibodies, reproducibility (research note)
171
Focus ELISA tests for HSV-1 and HSV-2
antibodies among women 530
serological investigation of prevalence of anti-
dengue IgM and IgG antibodies (research
note) 181
Epidemiology
acute hepatitis B in Turkey 537
amoxycillin-resistant Enterococcus faecium 441
catheter-related bloodstream infections in
Europe (research note) 843
infective endocarditis in Greece 556
infective endocarditis and host status 302
integrons as tools for epidemiological studies
156
Listeria monocytogenes typing for
epidemiological studies 562
molecular, penicillin-resistant Streptococcus
pneumoniae 718
Pneumocystis carinii pneumonia in southern
Spain (research note) 673
relatedness of MRSA isolated from geriatric
institution and hospital (research note) 339
streptococcal group B infections in western
Sweden 791
Erythromycin resistance, Streptococcus pneumoniae
851
Escherichia coli
b-lactamase production
ESBL CTX-M-15 (research note) 752
metallo-b-lactamase VIM-2 and ESBL IBC-1
(research note) 757
prevalence (research note) 760
quinolone resistance, community-acquired
urinary tract infections (research note) 75
relationship between ciprofloxacin resistance
and extended-spectrum b-lactamase
production (research note) 72
resistance, Egyptian children with diarrhoea
804
resistance mechanisms to
amoxycillin—clavulanic acid 234
virulence factors
a-haemolytic strains 569
production and pathogenic role of
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siderophore and other virulence factors
(research note) 1011
Escherichia coli O157, verocytotoxigenic, from
unpasteurised milk, as cause of haemolytic
uraemic syndrome (research note) 576
Etest
metronidazole resistance determination in
Helicobacter pylori 315
oxacillin susceptibility testing, coagulase-
negative staphylococci (research note) 462
European Antimicrobial Resistance Surveillance
System (EARSS), Streptococcus pneumoniae
resistance to macrolides (research note)
851
Extended-spectrum b-lactamases see under
b-lactamases
Eyach virus 1050
Faropenem, protein binding, influence on
antibacterial activity against Haemophilus
influenzae (research note) 934
Fascioliasis (editorial) 385
Febrile neutropenia, diagnostic value of
procalcitonin 628
Ferritin, serum levels in West Nile encephalitis
(research note) 184
Flavivirus infections, Europe (review) 1040
Fluoroquinolones, resistance in Streptococcus
pyogenes isolate (research note) 659
Food infections
Campylobacter (review) 868
restaurant-associated outbreak of Salmonella
Typhimurium 904
Salmonella Enteritidis in Bosnia and
Herzegovina (research note) 1031
Fungaemia
cancer patients, significance of blood cultures
positive for saprophytic moulds (research
note) 922
Fusarium, immunocompromised patients
(editorial) 499
Fusarium spp.
fungaemia in immunocompromised patients
(editorial) 499
fungal keratitis (editorial) 773
Fusidic acid, penetration into cerebrospinal fluid
in Staphylococcus epidermidis meningitis
(research note) 765
Ganciclovir prophylaxis, cytomegalovirus disease
in kidney recipients undergoing anti-
lymphocyte globulin treatment (research
note) 337
Gastroenteritis
associated pathogens, rural Jordan 634
astrovirus infection, Italian children (research
note) 1025
Campylobacter (review) 868
Gatifloxacin, community-acquired pneumonia
403
comparison with co-amoxiclav 512
Gemifloxacin, inhibition of cytokine secretion by
lipopolysaccharide-stimulated monocytes
213
Gene cassettes, integrons and super-integrons
(review) 272
Giardiasis, albendazole treatment in childhood
infection 527
GISA see Glycopeptide-intermediate
Staphylococcus aureus
Gloves, testing for viral penetration of non-latex
gloves 322
Glutaraldehyde, detection of residue on clinical
materials 984
Glycopeptide-intermediate Staphylococcus aureus
(GISA)
false synergy of combined vancomycin and b-
lactam treatment (research note) 342
French hospitals 448, 459 (research note)
Glycopeptide-resistant Enterococcus faecalis, inter-
hospital dissemination (research note) 260
Gram-negative bacteria, efflux-mediated
multiresistance (review) 12
Gram-positive cocci, activity of linezolid against
242
HAART, effect on tuberculosis manifestations 388
HACEK group, infective endocarditis in Greece
556
Haematological disease, reduced susceptibility to
penicillin of viridans group streptococci 899
Haemolytic uraemic syndrome, outbreak caused
by verocytotoxigenic Escherichia coli O157
from unpasteurised cow’s milk (research
note) 576
Haemophilus influenzae
influence of protein binding on antibacterial
activity of faropenem (research note) 934
PCR-based serotyping 895
Helicobacter pylori
bronchiectasis patients (research note) 257
cagA and vacA genotypes 41
peptic ulcer disease and non-ulcer dyspepsia
(research note) 1102
genetic characterisation of isolates from
Argentinean adults 811
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infection in non-institutionalised children with
mental retardation (research note) 670
metronidazole resistance determination 315,
1105 (correspondence)
Hepatitis B
acute, epidemiology and genotype distribution,
Turkey 537
antibodies, hepatitis C infection and (research
note) 70
Hepatitis C
and hepatitis B antibodies (research note) 70
and HIV co-infection, modifications of
haematological series during interferon/
ribavirin treatment 1067
intravenous drug users (research note) 768
plasma samples, multiplex RT-PCR detection of
hepatitis C and HIV 1075
Hepatitis D, acute hepatitis B virus infection in
Turkey 537
Herpes simplex virus (HSV), Focus ELISA tests
for HSV-1 and HSV-2 antibodies among
women 530
Highly active anti-retroviral therapy see HAART
HIV (human immunodeficiency virus)
CD4 T-lymphocyte counts in HIV-seropositive
patients with community-acquired
pneumonia caused by Streptococcus
pneumoniae (research note) 587
Chlamydia pneumoniae in HIV-infected patients
820
and hepatitis C co-infection, modifications of
haematological series during interferon/
ribavirin treatment 1067
plasma samples, multiplex RT-PCR detection of
hepatitis C and HIV 1075
pol gene insertions in HIV-1 as cause of
persistent failure of antiretroviral drugs 127
prevalence of resistance substitutions in HIV-1
genes 826
protease inhibitor-resistant, effect of
polymorphisms on replicative capacity of
HIV-1 under drug pressure 119
tuberculosis in HIV-infected patients (review)
388
Hydrogen peroxide, detection of residue on
clinical materials 984
Imipenem
effect of sub-inhibitory concentrations on
Acinetobacter baumannii (research note) 931
and sulbactam, synergistic activity against
Actinobacter baumannii (research note) 1098
Immigrants see Migrants
Immunocompromised hosts, Fusarium fungaemia
(editorial) 499
Immunoglobulins
chronological evolution of IgM, IgA and IgG
after SARS-associated coronavirus infection
1062
Mycoplasma pneumoniae IgM-, IgG- and IgA-
specific enzyme immunoassays in blood
donors and patients (research note) 1094
Integrons
resistance integrons and super-integrons
(review) 272
as tools for epidemiological studies 156
Intensive care units (ICUs)
multiresistant Acinetobacter baumannii, use of
inhaled ampicillin—sulbactam against
(correspondence) 85
third-generation cephalosporin-resistant
Enterobacteriaceae 436
Interferon—ribavirin therapy, modifications of
haematological series in HIV—hepatitis C
co-infection 1067
Interferon-c assay, assessment of Chlamydia
pneumoniae in HIV-infected patients 820
Joints, prosthetic, treatment of infections 831
Keratitis, fungal, Fusarium spp. (editorial) 773
Ketolides, stock solutions for antimicrobial
susceptibility tests (research note) 78
Kidney transplantation, ganciclovir prophylaxis
to prevent CMV in patients undergoing
anti-lymphocyte globulin treatment for
acute rejection (research note) 337
Klebsiella pneumoniae
b-lactamase production
CTX-M-15 (research note) 752
prevalence (research note) 760
phylogenetic groups, identification and
antimicrobial resistance (research note) 942
relationship between ciprofloxacin resistance
and extended-spectrum b-lactamase
production (research note) 72
Labchips (editorial) 865
Leclercia adecarboxylata, antimicrobial
susceptibility and identification 724
Leukaemia
acute, treatment of fungal pneumonia with
caspofungin and amphotericin B or
voriconazole (research note) 255
reduced susceptibility to penicillin of viridans
group streptococci 899
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Leukoscintigraphy, brucellar spondylitis
(research note) 1020
Levofloxacin susceptibility among respiratory
pathogens, Brazil 521
Linezolid, activity against Gram-positive cocci
242
Listeria monocytogenes typing 562
Louping ill virus 1051
Lung abscess, ampicillin + sulbactam vs
clindamycin ± cephalosporin 163
Lyme borreliosis (review) 598
guidelines for diagnosis 1108
seroprevalence in forestry rangers 1056
Lymphocytosis, cytomegalovirus infection and
(research note) 468
Lymphopenia, HIV—HCV patients treated with
interferon and ribavirin 1067
Macrolides
stock solutions for antimicrobial susceptibility
tests (research note) 78
Streptococcus pneumoniae resistance to (research
note) 851
Mecillinam, urine concentrations and urine ex-
vivo effect 54
Media: simplified sunflower seed agar for
differentiation of Candida dubliensis from
Candida albicans (research note) 590
Melanoma metastasis site, abscess caused by
Salmonella enterica serovar Enteritidis
(correspondence) 86
Melioidosis, cell-mediated immune response
following exposure to Burkholderia
pseudomallei (research note) 585
Meningitis
adult bacterial 709
echovirus 13, Lithuanian children (research
note) 1023
Haemophilus influenzae, PCR-based serotyping
895
Staphylococcus epidermidis, penetration of fusidic
acid and rifampicin into cerebrospinal fluid
(research note) 765
see also Neisseria meningitidis
Meropenem, effect of sub-inhibitory
concentrations on Acinetobacter baumannii
(research note) 931
Meropenem Yearly Susceptibility Test
Information Collection (MYSTIC)
programme, survey of awareness and
perceptions of ESBLs (research note) 760
Methicillin-resistant Staphylococcus aureus (MRSA)
bloodstream infections 309
carriage in repatriates from foreign hospitals to
The Netherlands 972
cefoxitin disk diffusion test (research note) 762
epidemiological relatedness of isolates from
geriatric institution and hospital (research
note) 339
evolution, multilocus sequence typing and
(review) 92
Panton—Valentine leukocidin gene, detection
by LightCycler PCR 884
with reduced susceptibility to glycopeptides see
Glycopeptide-intermediate Staphylococcus
aureus
use of teicoplanin 62
Methylprednisolone, treatment of SARS (research
note) 676
Metronidazole resistance determination,
Helicobacter pylori 315, 1105
(correspondence)
Micafungin with voriconazole, invasive
pulmonary aspergillosis (research note)
925
Microarrays (editorial) 865
Migrants
drug-resistant tuberculosis (research note) 335
schistosomal appendicitis (editorial) 89
Milk, unpasteurised, as source of outbreak of
haemolytic uraemic syndrome caused by
verocytotoxigenic Escherichia coli O157
(research note) 576
Molecular diagnostics
nucleic acid amplification tests for detection of
Mycobacterium tuberculosis 295
real-time PCR (review) 190
Molecular typing, role in clinical management of
infection (editorial) 269
Mononegavirales, matrix proteins (research note)
945
MOP-UP (computer program) (research note) 948
Multilocus sequence typing (MLST) and
evolution of MRSA (review) 92
Mycobacteria
detection and recovery, comparison of MB/
BacT system with Middlebrook 7H11 and
Lowenstein—Jensen media 224
diagnosis of disseminated infections by bone
marrow and blood cultures 734
non-tuberculous, vertebral osteomyelitis
(editorial) 951
Mycobacterium flavescens, isolation of novel
sequevar from AIDS patient (research note)
1017
Mycobacterium kansasii pneumonia 738
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Mycobacterium tuberculosis
cancer patients (research note) 749
detection
BDProbeTec MTB assay compared with
AMTD II assay (research note) 333
nucleic acid amplification methods, quality
control study 295
diagnostic testing, Italy (research note) 1014
drug resistance among immigrants (research
note) 335
rifampicin resistance, DNA probe array for
detecting rpoB mutations 289
rifampicin-resistant isolates with rpoB
mutations, activity of rifabutin against
(research note) 662
see also Tuberculosis
Mycoplasma pneumoniae antibodies
enzyme immunoassays in blood donors and
patients (research note) 1094
possible association with asthma (research
note) 345
MYSTIC programme see under Meropenem
Nairovirus, tick-borne 1047
Nalidixic acid, increasing incidence of resistance
in shigellas (research note) 1033
Neisseria meningitidis
identification of N. meningitidis sequence type
66 in Poland (research note) 848
outbreak of N. meningitidis B:15:P1.12, sequence
type 403 (research note) 845
risk factors for carriage by Greek children 137
Neutralisation antibody, chronological evolution
after SARS-associated coronavirus infection
1062
Neutropenia
febrile, diagnostic value of procalcitonin 628
HIV—HCV patients treated with interferon and
ribavirin 1067
Nikkomycin Z alone or in combination, in-vitro
activity against Aspergillus fumigatus 961
Nosocomial infections
catheter-related see Catheter-related infections
control in Europe (research note) 263
glycopeptide-resistant Enterococcus faecalis
(research note) 260
risk factors for infection with Candida spp. 550
Staphylococcus aureus blood stream infections
309
third-generation cephalosporin-resistant
Enterobacteriaeceae
ICU patients 436
Tunisia (research note) 665
use of inhaled ampicillin—sulbactam against
multiresistant Acinetobacter baumannii in
ICU patients (correspondence) 85
Nucleic acid amplification tests, Mycobacterium
tuberculosis
BDProbeTec strand amplification assay
compared with AMTD II assay (research
note) 332
quality control study 295
NVP PDF-713 (LBM 415) (peptide deformylase
inhibitor) (research note) 857
Omsk haemorrhagic fever 1046
OSIRIS video reader as automated measurement
system for disk diffusion technique 416
Osteomyelitis, vertebral, caused by non-
tuberculous mycobacteria (editorial) 951
Otitis media, Turicella otitidis and (research note)
854
Oxacillin susceptibility testing, coagulase-
negative staphylococci (research note) 462
Oxazolidinones, in-vitro properties of AZD2563
247
Panton—Valentine leukocidin (PVL) gene,
Staphylococcus aureus, detection by
LightCycler PCR 884
Parasite pathogens, gastroenteritis in rural Jordan
634
PCR see Polymerase chain reaction
Penicillin
resistance
b-lactamase producing bacteria and (review)
777
Streptococcus pneumoniae 718, 851 (research
note)
susceptibility
adult bacterial meningitis 709
reduced susceptibility of viridans group
streptococci in haematological disease 899
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